Placebo to ezetimibe/atorvastatin
Sponsors
Organon and Co
Conditions
Hypercholesterolemia
Phase 3
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
CompletedNCT01370590
Start: 2011-09-30End: 2012-04-30Updated: 2022-02-09
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
CompletedNCT01370603
Start: 2011-09-30End: 2012-05-31Updated: 2022-02-09